Treatment of hepatitis C in difficult-to-treat patients.
about
Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspectiveHepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Injecting drug use: A vector for the introduction of new hepatitis C virus genotypesFibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantationThe impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.Natural HCV variants with increased replicative fitness due to NS3 helicase mutations in the C-terminal helix α18Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.Identification of Entry Factors Involved in Hepatitis C Virus Infection Based on Host-Mimicking Short Linear Motifs.Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease BurdenSimeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2)Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment.DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting.A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entry.Drug interactions in HIV-infected patients treated for hepatitis C.Development of an Aryloxazole Class of Hepatitis C Virus Inhibitors Targeting the Entry Stage of the Viral Replication Cycle.Detection of a genetic footprint of the sofosbuvir resistance-associated substitution S282T after HCV treatment failure.Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease.Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients.Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.Viral hepatitis: A new HCV cell culture model for the next clinical challenges.Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus.Host-targeting therapies for hepatitis C virus infection: current developments and future applications.
P2860
Q26746910-DB659D8C-68CA-4CE8-B89E-125298E3C265Q26750997-BA0EA22D-1E76-451C-8BB9-8FE7668405BFQ26781991-39AD46AC-0729-460A-ABAB-59DC03BC3FCAQ28076406-4D0254DA-7F88-4974-A5E6-C222BA8C0A88Q30250096-5CB97E00-2453-4E79-88CC-048B9F16B5F6Q30383665-681AF531-80E0-45E6-A568-99B21170FFDEQ30386551-94EC3F09-2A3B-432C-8BF2-C9167D902064Q36166222-C9939750-44A7-43C7-AE46-73C7865F8475Q36262482-674702FD-62F3-4B9C-B2D7-64F9687BD80DQ36270505-2E79F1E2-E068-4068-968A-A831CAB3E1FFQ37246465-F615E2F0-5DEE-4808-A49A-3F4B37210F12Q37631758-2FDD11D9-C408-4A55-A6F5-DC2B7C912FB0Q38554604-C53EB958-3489-47A6-ABC6-17D4D5B4A957Q38634755-11C9891E-E76F-4639-B61E-61FC3F9B59F0Q38838703-F2F5A3C9-B601-40B5-A73A-85B398BE881DQ39749560-D24DC079-8FEF-494A-8C37-2FB9CC385972Q40126459-0CED6739-5F9E-4280-A367-48243D7D1E45Q40143109-AA10D78F-D789-4907-AE44-638B3AA4F4C5Q40151324-F6DE8AA5-1A76-44B8-93E9-167ADB54E05CQ40167095-7CD2462B-78FB-42F9-871A-9D542494CA9EQ40438926-477C4973-6C08-4099-83A7-AEEBA3AFD9CCQ40584662-6D4C4B1E-527B-4D1D-A773-112E47907646Q40712261-CB86E321-9D59-4E72-805D-84532BA2E82BQ42983711-C96A7FE3-35AE-4FAC-9016-5601A590500FQ54245484-27D80616-3D2F-4A56-BCE4-653ACB36CEC3Q55280981-4701B83C-1BEE-4708-8914-B9743038BAE9
P2860
Treatment of hepatitis C in difficult-to-treat patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Treatment of hepatitis C in difficult-to-treat patients.
@en
type
label
Treatment of hepatitis C in difficult-to-treat patients.
@en
prefLabel
Treatment of hepatitis C in difficult-to-treat patients.
@en
P2860
P356
P1476
Treatment of hepatitis C in difficult-to-treat patients.
@en
P2093
Peter Ferenci
P2860
P2888
P304
P356
10.1038/NRGASTRO.2015.53
P407
P577
2015-04-21T00:00:00Z